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The production of reactive oxygen species (ROS) by activated macrophages and neutrophil granulocytes 
represents an important cause of alcohol-induced oxidative stress and significantly contributes to the 
pathogenesis of alcoholic liver disease (ALD) [1].  Furthermore, diffuse neutrophil infiltration of the liver is a 
key feature of acute alcoholic hepatitis actively participating to parenchymal injury [2].  However, during 
ALD progression to cirrhosis, neutrophil functions such as ROS production, bacterial phagocytosis and 
granule exocytosis are impaired
 
leading to an increased susceptibility to bacterial infections of cirrhotic 
patients [3]. Indeed, the development of bacterial peritonitis is a common complication of cirrhosis, while 
sepsis is a major cause of mortality of patients with decompensated alcoholic cirrhosis being also 
associated with multi-organ failure and immune deficiencies [4].  
The key role o  neutrophils in anti-bacterial defences mainly relies on the capacity of the enzyme NADPH 
oxidase 2 (NOX2) to generate superoxide anion (O2
-
) during a process known as oxidative burst. Superoxide 
anion, in fact, by conversion to hydrogen peroxide fuels myeloperoxidase-mediated production of the 
powerful bactericidal agents, hypochlorite and chloramine [5].  NOX2 is a multi-protein enzymatic system 
consisting of the transmembrane proteins gp91
phox
 and p22
phox
 forming the catalytic unit flavocytochrome 
b558 and of several cytosolic components, including the p67
phox
, p47
phox
, p40
phox
 and Rac1/2 sub-units [5].
 
Upon phosphorylation of p47
phox
, the different sub-units assemble to the plasma membrane forming the 
active enzyme. Thus, an efficient ROS production requires an optimal expression of all the NOX2 
components and coordinated signals driving the enzyme assembly [5].   
In this issue, Rolas and co-workers [6] add further insights into the mechanisms responsible for the deficit 
in neutrophils’ bactericidal activity that characterizes alcoholic cirrhosis by investigating some of the 
mechanisms responsible for the impairment of ROS production by NOX2.  They report that the deficiency in 
oxidative burst that characterizes the response to formylated peptides (f-MLP) of neutrophils from 
decompensated cirrhotic patients was associated with a severe reduction in the intracellular content of 
gp91
phox
, p22
phox
 and p47
phox
, despite their unchanged mRNA levels.   By investigating the mechanisms 
involved they observed that the decrease of gp91
phox
 was partially due to an enhanced protein degradation 
due to elastase released by neutrophils themselves and more abundant in the plasma of cirrhotic patients. 
In addition, the lowering of NOX2 components also involved an impairment of protein synthesis 
consequent to the reduction of the kinase mammalian target of rapamycin (mTOR), a key regulator of 
cellular anabolic processes.  Interestingly, treating the neutrophils from cirrhotic patients with the Toll-like 
receptor-7/8 (TLR-7/8) agonists CL097 and R848 restored ROS production by stimulating the synthesis of 
NOX2 components through a process involving mTOR activation.  TLR-7/8 agonists were also active when 
added to whole blood, while the use of the elastase inhibitor N-(Methoxysuccinyl)-Ala-Ala-Pro-Val-
chloromethylketone (NEI) had a minimal impact on NOX2 recovery.  The effect of TLR agonists was rather 
specific, as the TLR-4 stimulation by lipopolysaccharide enhanced gp91
phox
 expression, but modestly 
improved ROS production. Such a specificity might likely relate to the capacity of TLR-7/8-mediated signals 
to potentiate NOX2 activity through the phosphorylation of p47
phox
 by protein kinase B (PKB; AKT), mTOR 
and p38 mitogen activated kinase (p38MAPK) [7] (Fig. 1).   From these data, the authors conclude that 
elastase-dependent degradation and mTOR impairment contributes to the decrease gp91
phox
 and ROS 
production observed in patients with alcoholic cirrhosis. However, the latter process appears be more 
relevant to explain the defect in ROS production, as protein synthesis can compensate for the loss of 
gp91
phox 
due to elastase-mediated degradation.  A deficit of gp91
phox
 also accounts for the lowering in ROS-
mediated bacterial killing by monocytes of patients with alcoholic hepatitis [8], indicating that in alcohol 
abusers similar mechanisms can be responsible for affecting the functions of different phagocytic cells.  
Interestingly, TLR-7/8 stimulation of AKT/mTOR also contributes to restore neutrophil’s bactericidal activity 
by promoting myeloperoxidase release [9] (Fig. 1). Nonetheless, several issues remain still open. For 
instance, little is known about the mechanisms that lead to the lowering of neutrophil mTOR in advanced 
ALD and it is still unclear how TLR-7/8 stimulation acts in reverting mTOR activity. On the other hand, the 
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presented data add to the consensus that mTOR inhibitors are most likely ill-advised as anti-fibrotic 
treatment in advanced liver fibrosis, as they will inevitably worsen the defective oxidative burst capacity of 
neutrophils and thus increase the risk of infections. 
In conclusion, this work nicely supports previous data from the same group pointing to a key role of 
AKT/mTOR in the mechanisms affecting the bactericidal activity of neutrophils in alcoholic cirrhosis [7,9].  
The significance of the presented data mainly derives from its possible clinical translation into using TLR-7/8 
agonists to reverse alcohol-mediated impairment of neutrophil ROS production, and thus improve the 
host’s antibacterial defence of patients with alcoholic (and non-alcoholic?) cirrhosis. Whether this could be 
implemented in a treatment of established infections or in their prevention remains to be determined.   
However, as a novel therapeutic target, TLRs clearly deserve further investigation in humans, particularly, 
since prophylactic antibiotic treatment in patients with cirrhosis achieves only a moderate benefit [10]. In 
this regard, it seems important to emphasize that TLR agonists have been shown to be effective in 
promoting both innate and adaptive immunity [11] and their use might exert a synergistic therapeutic 
effect with that of granulocyte colony-stimulating factor [12] in controlling infective complications of 
advanced ALD. 
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Figure caption 
Figure 1: Proposed mechanisms by which TLR-7/8 stimulation improves the antibacterial activity of 
neutrophils from patients with alcoholic cirrhosis.  Abbreviations: AKT protein kinase B; NOX2 NADPH 
oxidase 2; MPO myeloperoxidase; mTOR mammalian target of rapamycin; TLR-7/8 Toll-like receptor-7/8; 
O2
-
 superoxide anion; H2O2 hydrogen peroxide; HClO hypochlorous acid; p38MAPK p38 mitogen activated 
kinase; NOX2 NADPH oxidase 2; gp91
phox
, p22
phox
 p67
phox
, p47
phox
, p40
phox
, Rac1/2 NOX2 sub-units. 
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represents an important cause of alcohol-induced oxidative stress and significantly contributes to the 
pathogenesis of alcoholic liver disease (ALD) [1].  Furthermore, diffuse neutrophil infiltration of the liver is a 
key feature of acute alcoholic hepatitis actively participating to parenchymal injury [2].  However, during 
ALD progression to cirrhosis, neutrophil functions such as ROS production, bacterial phagocytosis and 
granule exocytosis are impaired
 
leading to an increased susceptibility to bacterial infections of cirrhotic 
patients [3]. Indeed, the development of bacterial peritonitis is a common complication of cirrhosis, while 
sepsis is a major cause of mortality of patients with decompensated alcoholic cirrhosis being also 
associated with multi-organ failure and immune deficiencies [4].  
The key role o  neutrophils in anti-bacterial defences mainly relies on the capacity of the enzyme NADPH 
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anion, in fact, by conversion to hydrogen peroxide fuels myeloperoxidase-mediated production of the 
powerful bactericidal agents, hypochlorite and chloramine [5].  NOX2 is a multi-protein enzymatic system 
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phox
 and p22
phox
 forming the catalytic unit flavocytochrome 
b558 and of several cytosolic components, including the p67
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, p40
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 and Rac1/2 sub-units [5].
 
Upon phosphorylation of p47
phox
, the different sub-units assemble to the plasma membrane forming the 
active enzyme. Thus, an efficient ROS production requires an optimal expression of all the NOX2 
components and coordinated signals driving the enzyme assembly [5].   
In this issue, Rolas and co-workers [6] add further insights into the mechanisms responsible for the deficit 
in neutrophils’ bactericidal activity that characterizes alcoholic cirrhosis by investigating some of the 
mechanisms responsible for the impairment of ROS production by NOX2.  They report that the deficiency in 
oxidative burst that characterizes the response to formylated peptides (f-MLP) of neutrophils from 
decompensated cirrhotic patients was associated with a severe reduction in the intracellular content of 
gp91
phox
, p22
phox
 and p47
phox
, despite their unchanged mRNA levels.   By investigating the mechanisms 
involved they observed that the decrease of gp91
phox
 was partially due to an enhanced protein degradation 
due to elastase released by neutrophils themselves and more abundant in the plasma of cirrhotic patients. 
In addition, the lowering of NOX2 components also involved an impairment of protein synthesis 
consequent to the reduction of the kinase mammalian target of rapamycin (mTOR), a key regulator of 
cellular anabolic processes.  Interestingly, treating the neutrophils from cirrhotic patients with the Toll-like 
receptor-7/8 (TLR-7/8) agonists CL097 and R848 restored ROS production by stimulating the synthesis of 
NOX2 components through a process involving mTOR activation.  TLR-7/8 agonists were also active when 
added to whole blood, while the use of the elastase inhibitor N-(Methoxysuccinyl)-Ala-Ala-Pro-Val-
chloromethylketone (NEI) had a minimal impact on NOX2 recovery.  The effect of TLR agonists was rather 
specific, as the TLR-4 stimulation by lipopolysaccharide enhanced gp91
phox
 expression, but modestly 
improved ROS production. Such a specificity might likely relate to the capacity of TLR-7/8-mediated signals 
to potentiate NOX2 activity through the phosphorylation of p47
phox
 by protein kinase B (PKB; AKT), mTOR 
and p38 mitogen activated kinase (p38MAPK) [7] (Fig. 1).   From these data, the authors conclude that 
elastase-dependent degradation and mTOR impairment contributes to the decrease gp91
phox
 and ROS 
production observed in patients with alcoholic cirrhosis. However, the latter process appears be more 
relevant to explain the defect in ROS production, as protein synthesis can compensate for the loss of 
gp91
phox 
due to elastase-mediated degradation.  A deficit of gp91
phox
 also accounts for the lowering in ROS-
mediated bacterial killing by monocytes of patients with alcoholic hepatitis [8], indicating that in alcohol 
abusers similar mechanisms can be responsible for affecting the functions of different phagocytic cells.  
Interestingly, TLR-7/8 stimulation of AKT/mTOR also contributes to restore neutrophil’s bactericidal activity 
by promoting myeloperoxidase release [9] (Fig. 1). Nonetheless, several issues remain still open. For 
instance, little is known about the mechanisms that lead to the lowering of neutrophil mTOR in advanced 
ALD and it is still unclear how TLR-7/8 stimulation acts in reverting mTOR activity. On the other hand, the 
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presented data add to the consensus that mTOR inhibitors are most likely ill-advised as anti-fibrotic 
treatment in advanced liver fibrosis, as they will inevitably worsen the defective oxidative burst capacity of 
neutrophils and thus increase the risk of infections. 
In conclusion, this work nicely supports previous data from the same group pointing to a key role of 
AKT/mTOR in the mechanisms affecting the bactericidal activity of neutrophils in alcoholic cirrhosis [7,9].  
The significance of the presented data mainly derives from its possible clinical translation into using TLR-7/8 
agonists to reverse alcohol-mediated impairment of neutrophil ROS production, and thus improve the 
host’s antibacterial defence of patients with alcoholic (and non-alcoholic?) cirrhosis. Whether this could be 
implemented in a treatment of established infections or in their prevention remains to be determined.   
However, as a novel therapeutic target, TLRs clearly deserve further investigation in humans, particularly, 
since prophylactic antibiotic treatment in patients with cirrhosis achieves only a moderate benefit [10]. In 
this regard, it seems important to emphasize that TLR agonists have been shown to be effective in 
promoting both innate and adaptive immunity [11] and their use might exert a synergistic therapeutic 
effect with that of granulocyte colony-stimulating factor [12] in controlling infective complications of 
advanced ALD. 
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